M. Ashton et al., ARTEMISININ KINETICS AND DYNAMICS DURING ORAL AND RECTAL TREATMENT OFUNCOMPLICATED MALARIA, Clinical pharmacology and therapeutics, 63(4), 1998, pp. 482-493
Objective: To compare parasite clearance times after oral and rectal a
dministration of artemisinin in adults with uncomplicated malaria and
to relate pharmacodynamics with artemisinin kinetics and to disclose a
ny pharmacokinetic changes during treatment, Methods: Thirty male Viet
namese patients with falciparum malaria were randomized to treatment w
ith 500 mg artemisinin daily by either the oral or rectal route of adm
inistration. Parasite densities in capillary blood were determined by
microscopy every 4 to 6 hours. Artemisinin plasma concentrations on th
e first and last day of treatment were determined by HPLC and unbound
fractions in plasma were determined by ultrafiltration, Results: Mean
parasite clearance times and 95% confidence intervals (95% CI) were 25
(95% CI, 16 to 33) and 29 (95% CI, 23 to 35) hours during oral and re
ctal treatment, respectively. The bioavailability after rectal relativ
e to oral artemisinin was 30%, Artemisinin areas under the plasma conc
entration-time curve (AUC) on the fifth (last) day of oral or rectal t
reatment were 30% (95% CI, 4% to 56%) and 40% (95% CI, -6% to 91%), re
spectively, of those after the first dose, The fraction unbound in pla
sma was 15% (95% CI, 12% to 19%), increasing marginally during treatme
nt. No relationship was found between main clinical end points and dru
g exposure, although indices for the rapidity of response onset were l
ower after oral treatment and correlated to unbound AUC values (r(s) =
-0.7; P < 0.001). Conclusions: The similarity in parasite clearance t
imes despite lower drug levels during rectal treatment suggests that i
nitial oral doses map be unnecessarily high, The singular time depende
ncy of artemisinin pharmacokinetics, attributed to autoinduction of dr
ug elimination, has possible implications for combination chemotherapy
, Decreasing artemisinin concentrations during treatment may partly ex
plain recrudescences and increase the risk for resistance development.